within Pharmacolibrary.Drugs.ATC.J;

model J05AC02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 5.166666666666667e-06,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0050999999999999995,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J05AC02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Rimantadine is an antiviral drug that inhibits replication of influenza A viruses by targeting the viral M2 protein. It was widely used for prophylaxis and treatment of influenza A, but its clinical use has been limited due to widespread resistance. Rimantadine is not currently recommended in many countries due to this resistance, but it retains pharmacological relevance for research and select cases.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers; both sexes, typically aged 18–65 years. Single oral dose administered under fasting conditions.</p><h4>References</h4><ol><li><p>Hoffman, HE, et al., &amp; Whitney, CC (1988). Pharmacokinetics and metabolism of rimantadine hydrochloride in mice and dogs. <i>Antimicrobial agents and chemotherapy</i> 32(11) 1699–1704. DOI:<a href=&quot;https://doi.org/10.1128/AAC.32.11.1699&quot;>10.1128/AAC.32.11.1699</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3252751/&quot;>https://pubmed.ncbi.nlm.nih.gov/3252751</a></p></li><li><p>Atiee, G, et al., &amp; Hernandez, J (2012). Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humans. <i>Journal of clinical pharmacology</i> 52(9) 1410–1419. DOI:<a href=&quot;https://doi.org/10.1177/0091270011414574&quot;>10.1177/0091270011414574</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21960669/&quot;>https://pubmed.ncbi.nlm.nih.gov/21960669</a></p></li><li><p>Atmar, RL, et al., &amp; Couch, RB (1990). Safety and pharmacokinetics of rimantadine small-particle aerosol. <i>Antimicrobial agents and chemotherapy</i> 34(11) 2228–2233. DOI:<a href=&quot;https://doi.org/10.1128/AAC.34.11.2228&quot;>10.1128/AAC.34.11.2228</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2073113/&quot;>https://pubmed.ncbi.nlm.nih.gov/2073113</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J05AC02;
